建禹集團(08196.HK)料上半年除税後淨虧損少於1000萬元
格隆匯 7 月 24日丨建禹集團(08196.HK)公佈,集團預期截至2020年6月30日止6個月的除税後淨虧損將不少於人民幣1,000萬元,比去年同期的除税後淨虧損約人民幣480萬元有顯著的增加。
董事會認為,除税後淨虧損主要由於新型冠狀病毒的爆發導致2020年上半年中國經濟錄得負增長,使國內供水及水處理設施的新增需求大幅放緩;新型冠狀病毒導致2020年自春節假期後項目開工時間出現延誤;由於新型冠狀病毒防疫政策導致人手短缺,在建項目為須應對防疫及工期雙重要求而需付出額外成本;及於去年同期自出售一間附屬公司錄得約人民幣457.8萬元的一次性收益,而今年則無錄得有關收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.